TIDMABZA

Abzena PLC

03 May 2017

Hardman Research: Acceleration towards profitability

Acceleration towards profitability: Abzena is an integrated group offering a broad range of services and technologies to improve the chances of discovering and developing effective biopharmaceutical drugs. With strong footprints in both the US and UK, the company provides a fee-for-service offering with the aim of embedding its technology - 'Abzena Inside' - into commercial products, on which it will derive a long-term royalty stream. New funds will be invested to significantly increase capacity and current service capabilities in response to customers' needs and accelerate the rate at which Abzena becomes profitable and cash generative.

Please click here for the full report:

http://hardmanandco.com/docs/default-source/company-docs/abzena-plc-documents/abza_placing-update_3rd-may-2017-(003).pdf

 
 To contact us:         Analysts: 
  Hardman & Co           Dr Martin Hall mh@hardmanandco.com 
  35 New Broad Street    Dr Dorothea Hill dmh@hardmanandco.com 
  London                 Dr Gregoire Pave gp@hardmanabdco.com 
  EC2M 1NH               Telephone: +44 207 929 3399 
                         Follow us on Twitter @HardmanandCo

www.hardmanandco.com

About Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRASSAFWEFWSEDI

(END) Dow Jones Newswires

May 03, 2017 02:15 ET (06:15 GMT)

Abzena (LSE:ABZA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Abzena Charts.
Abzena (LSE:ABZA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Abzena Charts.